Identification of Clinically Significant Prostate Cancer by Combined PCA3 and AMACR mRNA Detection in Urine Samples

PURPOSE: Preclinical evaluation of PCA3 and AMACR transcript simultaneous detection in urine to diagnose clinical significant prostate cancer (prostate cancer with Gleason score ≥7) in a Russian cohort. PATIENTS AND METHODS: We analyzed urine samples of patients with a total serum PSA ≥2 ng/mL: 31 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotova, Elena S, Savochkina, Yulia A, Doludin, Yuriy V, Vasilyev, Alexander O, Prilepskay, Elena A, Potoldykova, Natalia V, Babalyan, Konstantin A, Kanygina, Alexandra V, Morozov, Andrey O, Govorov, Alexander V, Enikeev, Dmitry V, Kostryukova, Elena S, Ilina, Elena N, Govorun, Vadim M, Pushkar, Dmitry Y, Sharova, Elena I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505712/
https://www.ncbi.nlm.nih.gov/pubmed/32984088
http://dx.doi.org/10.2147/RRU.S262310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505712/
https://www.ncbi.nlm.nih.gov/pubmed/32984088
http://dx.doi.org/10.2147/RRU.S262310

Ejemplares similares